Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: Comparison of clinical features and outcomes

Clinical Infectious Diseases

Volumn 26, Issue 5, 1998, Pages 1127-1133

  Lucas, Gregory M ^a,d   Lechtzin, Noah ^a   Wonder Puryear, D ^a,b   Yau, Linda L ^a,c   Flexner, Charles W ^a   Moore, Richard D ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Baltimore Medical Center   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTINEOPLASTIC AGENT; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; IMMUNOSUPPRESSIVE AGENT; METRONIDAZOLE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STOMACH SECRETION INHIBITOR; SUCRALFATE; SULFONAMIDE; TETRACYCLINE; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; CASE CONTROL STUDY; CENTRAL VENOUS CATHETERIZATION; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DRUG USE; ENTEROCOCCUS; FEMALE; HOSPITAL PATIENT; HUMAN; HYPERALIMENTATION; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 0031925669     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520311     Document Type: Article

References (33)

1. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci [letter]. Lancet 1988;1:57-8.
2. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988;319:157-61.
3. Frieden TR, Munsiff SS, Low DE, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;342:76-9.
4. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacter-emia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363-7.
5. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994;34:515-28.
6. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
7. Weinstein JW, Roe M, Town M, et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol 1996;17:36-41.
8. Morris JG, Shay DK, Hebden JN, et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: establishment of endemicity in a university medical center. Ann Intern Med 1995;123:250-9.
9. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. MMWR Morb Mortal Wkly Rep 1993;42:597-9.
10. Spera RV, Farber BF. Multidrug-resistant Enterococcu faecium: an untreatable nosocomial pathogen. Drugs 1994;48:678-88.
11. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990;3:46-65.
12. Murray BE. Vancomycin-resistant enterococci. Am J Med 1997;101:284-93.
13. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on the acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125:448-56.
14. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996;22:663-70.
15. Montecalvo MA, Shay DK, Patel P, et al. Bloodstream infections with vancomycin-resistant enterococci. Arch Intern Med 1996;156:1458-62.
16. Stroud L, Edwards J, Danzig L, Culver D, Gaynes R. Risk factors for mortality associated with enterococcal bloodstream infections. Infect Control Hosp Epidemiol 1996;17:576-80.
17. Edmond MB, Ober JE, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995;20:1126-33.
18. Shay DK, Maloney SA, Montecalvo M, et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
19. Facklam RR, Sahm DF. Enterococcus. In: Murray PR, Baron EJ, Phaler MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology 1995:308-14.
20. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 3rd ed. NCCLS document M7-A3. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1994.
21. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-28.
22. Barrall DT, Kenney PR, Slotman GJ, Burchard KW. Enterococcal bacteremia in surgical patients. Arch Surg 1985;120:57-63.
23. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988;67:248-69.
24. Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome. Clin Infect Dis 1995;20:296-301.
25. Shlaes DM, Levy J, Wolinski E. Enterococcal bacteremia without endocarditis. Arch Intern Med 1981;141:578-81.
26. Malone DA, Wagner RA, Myers JP, Watanakunakorn C. Enterococcal bacteremia in two large community teaching hospitals. Am J Med 1986;81:601-6.
27. Garrison NR, Fry DE, Berberich S, Polk HC. Enterococcal bacteremia: clinical implications and determinants of death. Ann Surg 1982;196:43-7.
28. Wells CL, Maddaus MA, Jechorek RP, Simmons RL. Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis 1988;7:107-13.
29. Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL. Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun 1987;55:2689-94.
30. Wells CL, Jechorek RP, Maddaus MA, Simmons RL. Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice. Antimicrob Agents Chemother 1988;32:1769-75.
31. Onderdonk AB, Bartlett JG, Louie T, Sullivan-Seigler N, Gorbach SL. Microbial synergy in experimental intra-abdominal abcess. Infect Immun 1976;13:22-6.
32. Bartlett JG, Louie TJ, Gorbach SL, Onderdonk AB. Therapeutic efficacy of 29 antimicrobial regimens in experimental intraabdominal sepsis. Rev Infect Dis 1981;3:535-41.
33. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.